ArticlePDF Available

PATTERNS OF NEURAL TUBE DEFECTS AT TWO TEACHING HOSPITALS IN ADDIS ABABA, ETHIOPIA A THREE YEARS RETROSPECTIVE STUDY

Authors:

Abstract and Figures

Background: Neural tube defects (NTDs), one of the most common congenital malformations, are potentially preventable cause of perinatal morbidity and mortality. Objectives: To give baseline description of NTDs and their outcome at two teaching hospitals in Addis Ababa, Ethiopia. Materials and Methods: A retrospective cross sectional descriptive study conducted from September 2009 to August 2012. Results: During the study period out of 28,961 deliveries 177 cases of NTDs were identified, giving an overall NTD prevalence of 6.1/1000. Only 12% (21/177) were diagnosed before 28 weeks of gestation. The mean gesta-tional age at diagnosis of NTDs was 33.8 weeks (±5.5). Majority, 93.2% (165/177), had antenatal care (ANC) follow up. Most, 72% (127/177), were diagnosed by ultrasound before delivery while 28% (50/177) were identified at the time of delivery or expulsion. Majority, 85.3% (151/177), never received folic acid supplementation. Only less than 1% (2/177) of the mothers started taking folic acid supplementation pre-conceptionally. Only a third, 33.3% (59/177), of the fetuses were born alive while only 13.6% (24/177) were discharged alive. Myelomeningocele, identified in 51.4% (91/177), was the commonest NTD in this study. Conclusion and recommendations: The proportion of NTDs in this study is among the highest globally reported rates. The practice of periconceptional folic acid supplementation is negligible. And although most had ANC follow up the vast majority of NTDs were diagnosed late in the third trimester. It is, therefore, highly recommended to consider implementing national preventive strategies to reduce the prevalence of NTDs in Ethiopia.
Content may be subject to copyright.
119
Gemechu Sorri, Eyasu Mesfin, Ethiop Med J, 2015, Vol. 53, No. 3
ORIGINAL ARTICLE
PATTERNS OF NEURAL TUBE DEFECTS AT TWO TEACHING HOSPITALS IN
ADDIS ABABA, ETHIOPIA A THREE YEARS RETROSPECTIVE STUDY
Gemechu Sorri, MD1 Eyasu Mesfin, MD1
ABSTRACT
Background: Neural tube defects (NTDs), one of the most common congenital malformations, are potentially pre-
ventable cause of perinatal morbidity and mortality.
Objectives: TogivebaselinedescriptionofNTDsandtheiroutcomeattwoteachinghospitalsinAddisAbaba,
Ethiopia.
Materials and Methods: A retrospective cross sectional descriptive study conducted from September 2009 to Au-
gust 2012.
Results: During the study period out of 28,961 deliveries 177 cases of NTDs were identified, giving an overall
NTD prevalence of 6.1/1000. Only 12% (21/177) were diagnosed before 28 weeks of gestation. The mean gesta-
tional age at diagnosis of NTDs was 33.8 weeks (±5.5). Majority, 93.2% (165/177), had antenatal care (ANC) fol-
low-up. Most, 72% (127/177), were diagnosed by ultrasound before delivery while 28% (50/177) were identified at
the time of delivery or expulsion. Majority, 85.3% (151/177), never received folic acid supplementation. Only less
than 1% (2/177) of the mothers started taking folic acid supplementation pre-conceptionally. Only a third, 33.3%
(59/177), of the fetuses were born alive while only 13.6% (24/177) were discharged alive. Myelomeningocele,
identified in 51.4% (91/177), was the commonest NTD in this study.
Conclusion and recommendations: The proportion of NTDs in this study is among the highest globally reported
rates. The practice of periconceptional folic acid supplementation is negligible. And although most had ANC fol-
low-up the vast majority of NTDs were diagnosed late in the third trimester. It is, therefore, highly recommended
to consider implementing national preventive strategies to reduce the prevalence of NTDs in Ethiopia.
Key words: NTD, Myelomeningocele, Spina Bifida
1Department of Obstetrics & Gynecology, School of Medicine, AAU, Addis Ababa
INTRODUCTION
Neural tube defects (NTDs) are a group of severe
human congenital malformations caused by the de-
fective closure of neural tube between 21 to 28 days
following conception. They represent one of the most
common congenital malformations in neonates
worldwide (1). NTDs can be classified as open or
closed, depending on whether neural tissues are ex-
posed or covered by skin, respectively. Open NTD
are more frequent and include spina bifida
(myelomeningocele), anencephaly, encephalocele,
hydranencephaly, iniencephaly and schizencephaly
(2).
The worldwide prevalence of NTDs ranged from 1 to
10 per 1000 (3). Each year, 300,000 to 400,000 in-
fants worldwide are born with NTDs including spina
bifida and anencephaly (4). They remain an impor-
tant yet potentially preventable cause of perinatal
morbidity and mortality. The risk of death is depend-
ant on the severity of the lesion and on other factors
such as the availability of medical and surgical re-
sources (5). All anencephalic children are stillborn or
die soon after birth. Children with meningocele and
myelomeningocele have higher survival rates, gener-
ally due to extensive medical care and surgery.
The exact cause of NTDs is not known. The aetiol-
ogy, however, includes both genetic and environ-
mental factors. Maternal socioeconomic status, geo-
graphic area, occupational exposure, maternal use of
antiepileptic drugs, education, and maternal nutrient
120
deficiency have been associated with variations in
the incidence (6,7). The best known risk factor for
foetal NTD is maternal folate deficiency (8, 9). And,
screening tests for NTDs include ultrasound exami-
nation and measurement of Maternal Serum Alpha-
Fetoprotein (MSAFP) at 16–18 weeks of gestation
(10). Screening decreases morbidity and mortality by
promoting access to earlier diagnosis, enabling fami-
lies to make informed reproductive choices, and de-
signing appropriate strategies for prenatal care and
delivery.
Prenatal maternal screening programs with termina-
tion of affected pregnancies combined with pericon-
ceptional folic acid supplementation and food fortifi-
cation have led to a decrease in the prevalence of
NTDs where these interventions are practiced (11-
17). For example, the incidence of NTDs in England
and Wales declined by 96 percent between 1970 and
1997: from approximately 3.2 per 1000 births to 0.1
per 1000 births (13). Forty percent of the decline was
attributed to antenatal screening with termination of
affected pregnancies and 56 percent was attributed to
a decline in incidence, due at least in part to an in-
crease in dietary folate intake. In addition, random-
ized trials have consistently shown peri-conception
folic acid supplementation to be one of the public
health interventions effective in reducing the risk of
NTDs (12,18). Data from randomized trials also indi-
cate that periconceptional folic acid supplementation
reduces the risk of recurrent NTDs by about 70 per-
cent (19).
Published data on NTDs in Ethiopia is very limited.
One retrospective review of 115 children with neural
tube defect (NTD) conducted from January, 2001 to
June 2005 at Ethio Swedish Children's Hospital at
Tikur Anbessa Hospital showed the most common
defect seen to be myelomeningocele (64.4%); fol-
lowed by meningocele (18.3%) and encephalocele
(13.0%). Associated anomalies like clubfoot un-
descended testis, different types of hernias, hydro-
celes etc. were noted in 28.7% of the patients (20).
Neurosurgical service provided in Ethiopia is also
very limited. A local study done in neurosurgical
department on pediatric patients awaiting admission
to Tikur Anbessa Hospital (TAH) from July 2006-
February 2007 demonstrated that there were 338
children in waiting lists out of which 41% were mye-
lomenigeocele and 29% were hydrocephalus. In ad-
dition, the average waiting time for admission was
447 days and the patients had to travel 300 miles on
average as most of them come from rural part of
Ethiopia (21).
Neither routine supplementation of folic acid for
women of reproductive age group nor routine screen-
ing for NTDs is practiced in the country. This study
was conducted at two teaching hospitals in Addis
Ababa, Ethiopia. And it is designed primarily to give
a baseline description of neural tube defects and their
outcome in our setup.
MATERIALS AND METHODS
This is a hospital based cross sectional descriptive
study done from September, 2009 to August, 2012 at
Tikur Anbessa Hospital (TAH) and Gandhi Memo-
rial Hospital (GMH), Addis Ababa, Ethiopia. It was
done through a retrospective review of charts of all
mothers who were admitted to the two teaching hos-
pitals and delivered or aborted a fetus with NTD.
Their Medical Record Numbers (MRN) identified
from admission log books in the maternity ward and
Neonatal Intensive Care Unit (ICU) were used to
retrieve medical records/charts. Data was collected
by the investigator using a pre-tested questionnaire
from medical records of the study participants. The
collected data was coded, cleaned and analyzed using
SPSS version 20 statistical software. Summary tables
and charts were used for describing data.
Ethical clearance was obtained from the research and
publication committee of the department of Obstet-
rics & Gynecology, and IRB of Addis Ababa Univer-
sity. Permission was also obtained from the Hospitals
to access the medical records of mothers included in
the study.
RESULT
During the study period there were a total of 28,961
deliveries in the two teaching hospitals. And, a total
of 177 mothers the outcome of whose pregnancies
was complicated with NTDs were identified. The
overall occurrence of NTDs in this study, hence, was
6.1/1000 births (live birth and fetal deaths). The
mean and median ages of the participant mothers
were 27.1 (±5.6) and 27 (IQR 7) respectively. Major-
ity were house wives and from Addis Ababa with
proportions of 48.6% (86/177) and 77.4% (137/177)
respectively. ( Table 1)
121
Table 1: Socio-demographic characteristics of mothers whose pregnancy outcome was complicated with NTDs
at twoteachinghospitals,AddisAbaba,Ethiopia,2009‐12.
Characteristics Frequency Percentage (n=177)
Address Addis Ababa 137 77.4 %
Out of Addis Ababa 40 22.6 %
Marital Status Married 163 92.1 %
Divorced 1 0.6 %
Single 13 7.3 %
Occupation House Wife 86 48.6 %
Governmental Employee 27 15.2 %
Private Employee 21 11.9 %
Factory worker 15 8.5 %
Student 14 7.9 %
Others 14 7.9 %
Primigravidity and gravida II were the commonest
gravidities each accounting for 43.5% (77/177) and
32% (57/177) respectively. The mean gravidity was
2±1.2 while the median gravidity was 2 (IQR = 2).
Only 12% (21/177) of the cases were diagnosed be-
fore 28 weeks of gestation. The mean gestational age
at diagnosis of NTDs was 33.8 weeks (±5.5). Majority
of the mothers, 93.2% (165/177), had ANC follow up.
The ANC follow up in 72.3% (128/177), 13%
(23/177) and 8% (14/177) of the mothers was in a
health center, private clinic and hospitals respectively.
Most of the NTDs, 72% (127/177), were diagnosed by
ultrasound before delivery while 28% (50/177) of
cases were identified at the time of delivery or expul-
sion. Majority, 85.3% (151/177), never received folic
acid supplementation throughout the entire pregnancy.
Only less than 1% (2/177) of the mothers started tak-
ing folic acid supplementation pre-conceptionally.
The rest, 3.4% (6/177) and 10.2% (18/177), of the
mothers received folic acid in the first and after first
trimesters respectively. (Table -2 ).
Medical illnesses were identified in 12.4% (22/177) of
the study participants. Hypertension, identified in
3.4% (6/177) of the mothers, was the commonest
medical illness, and diabetes, epilepsy and others were
found in 2.3% (4/177), 1.7% (3/177) and 4.5% of the
mothers respectively. The mode of delivery in about
74% (131/177) of the study participants was spontane-
ous vaginal. Cesarean section and laparatomy for uter-
ine rupture were done in 17.5% (31/177) and
0.1% (2/177) of the cases respectively. The rest, 7.3
% (13/177), were terminated medically. The indica-
tions for the cesarean sections were malpresentation
due to breech and transverse lie, previous C/S scar and
CPD in 48.5% (16/33), 18% (6/33) and 27% (9/33) of
the cesarean deliveries respectively. The diagnosis of
congenial malformation was made after delivery in
39% (12/31) of the mothers who delivered by cesar-
ean section.
Perinatal outcome: Majority of the neonates born to
the study subjects were females accounting for 72.3%
(128/177) with male to female ratio of 1:2.6. (Table 1)
Only a third, 33.3% (59/177), of the fetuses were born
alive while the rest 66.7% (118/177) were still born.
The mean birth weight was 1991 gm±951gm while
the median weight was 1900 gm (IQR=1650gm). Out
of the 59 live born neonates 40 (67.8%) had 1st minute
APGAR score of <6 whereas 19 (32.2%) had APGAR
score of >6. Death within few minutes of delivery and
before referral to Neonatal Intensive Care Unit
(NICU) occurred in 28.8% (17/59) of the live born
neonates. The rest, 71.2% (42/59) of the live born
neonates, were referred to NICU. Fifteen, 35.7%
(15/42), of the referred neonates died in the early neo-
natal period while in the NICU with the mean time of
death of 6.8 hrs. Only 12.3% (24/59) of the live born
neonates or 13.6% (24/177) of the total fetuses born or
expelled were discharged alive with appointment to
neurosurgical unit. The outcome of the admission was
not documented for three of the admitted cases. (Table
3)
122
Table -2: Obstetric characteristics of mothers whose pregnancy outcome was complicated with NTDs
at twoteachinghospitals,AddisAbaba,Ethiopia,2009‐2012. (n=177)
Characteristics Frequency Percentage, % (n=177)
Gravidity
I 77 43.5
II 57 32.2
III 24 13.6
IV 10 5.6
V 6 3.4
VI 3 1.7
GA at diagnosis of NTD
(n=177)
< 28 weeks 21 12
28 weeks 156 88
ANC follow up (n=177)
Yes
At health centre 128 72.2
At Hospital 23 13
At private facility 14 8
Sub total 165 93.2
No 12 6.8
Mode of NTD diagnosis
Ultrasound before delivery 127 72%
Identified after delivery/
expulsion
50 28%
Received folic acid supplemen-
tation
Yes
Preconception 2 1.1
During first trimester 6 3.4
After first trimester 18 10.2
Subtotal 26 14.7
No 151 85.3
123
Table 3: Perinatal outcome of mothers whose pregnancy was complicated with NTDs at two
TeachingHospitals,AddisAbaba,Ethiopia,2013. (n=177)
Characteristics Frequency Percentage, (n=177)
Sex
Male 49 27.7
Female 128 72.3
Pregnancy outcome at the time of delivery
Alive 59 33.3
Dead (Stillborn) 118 66.7
Pregnancy outcome at discharge
Alive 24 13.6
Dead
Still born 118 66.7
Death within few minutes of delivery
and before referral to NICU
17
9.6
Death after referral to NICU 15 8.5
Sub total 150 84.7
Unknown 3 1.7
Myelomeningocele, identified in 51.4% (91/177) of
the cases, was the commonest NTD in this study.
Anencephaly, encephalocele and meningeocele were
also the NTDs identified in 43.5% (77/177), 2.8%
(5/177) and 2.2% (4/177) of the neonates respec-
tively. Other associated congenital anomalies were
observed in 51.8% (92/177) of the neonates. The
most common associated anomaly observed was hy-
drocephalus identified in 37.8% (67/177).
The other associated anomalies include club foot and
gastrointestinal anomalies (omephalocele, gastroche-
sis, imperforated anus and diaphragmatic hernia)
identified in 6.8% (12/177) and 3.9% (7/177) neo-
nates respectively. (Table -4 )
Maternal post partum complications were identified
in 21(11.9%) of the mothers. These complications
include PPH secondary to uterine atony, uterine rup-
ture secondary to obstructed labor due to hydro-
cephalus and genital laceration occurring in 7 (4%),
2 (1.1%) and 12 (6.8%) of the mothers respectively.
124
Table 4: NTD type and associated anomalies identified in mothers whose pregnancy outcome
was complicated with NTDs at twoteachinghospitals,AddisAbaba,Ethiopia,2009‐2012. (n=177)
Characteristics Frequency Percentage, (n=177)
Type of NTD identified
Myelomeningocele 91 51.4
Anencephaly 77 43.5
Encephalocele 5 2.8
Meningeocele 4 2.2
Associated congenital anomaly (n=177)
Yes
Hydrocephalus 67 37.8
Club foot 12 6.8
GI anomalies 7 3.9
Cleft lip 2 1.1
Others 4 2.2
Sub total 92 52
No 85 48
DISCUSSION
One of the Millennium Development Goals initiated
by the United Nations was dedicated to reducing
global child mortality rates. Since 1990, global child
mortality has been declining largely due to the focus
on communicable diseases (22). This reduction of
mortality has led to the neglected causes of child
mortality to be exposed, including that of congenital
abnormalities (23). Neural tube defects (NTDs) are
one of the most common major birth defects second
in frequency only to congenital heart diseases (24).
The incidence of NTDs varies according to the geo-
graphic conditions, race, sex of the baby and certain
maternal conditions (25).
In most developed countries and many developing
countries like South Africa the incidence is less than
1/1000 mainly as a result of fortification of their diet
with folic acid and perinatal supplementation of folic
acid. Regardless of the progress in control of NTDs
observed in these countries, NTD continue to be a
problem of significant public health impact in our
setup. In this study the overall prevalence of NTDs
was found to be 6.1/1000 deliveries.This prevalence
of NTDs in this study (6.1/1000) is 5 and 9 times
higher than reports from South Africa (1.4/1000) and
Thailand (0.67 /1,000 births) respectively.
Only 15% of mothers were seen to have been supple-
mented with folic acid, 69% of which received the
supplementation in the third trimester when it has no
protective effect. This could be due to lack of knowl-
edge of the importance of folic acid in reducing the
prevention of NTDs by the mothers as well as health
care providers (26). This is in agreement to a prior
study done by Mohammed at Jigjiga University Hos-
pital on supplement use among pregnant women in
Ethiopia, in which 76.4% women claimed no aware-
ness about the benefits of early supplementation and
particularly folic acid intake was found to be negligi-
ble during the prenatal as well as antenatal period
(27).
The most common type of NTD observed in this
study was myelomeningocele 91(51.4%) followed by
anencephaly 77(43.5%). This finding is in agreement
with most other international studies (28-31). Similar
study done at Tikur Anbessa Ethio-Sewdish Hospital
and published in 2009 found the most common
125
anomaly to have been myelomeningocele (64.4%)
and meningocele 18.3 % (20). The study, however,
was conducted in NICU where only live neonates
were referred leading to higher proportion of alive
spina bifida which had better prognosis while exclud-
ing anencephalic babies which die soon after deliv-
ery.
NTDs were observed to occur more commonly in
females in our study with male to female ratio of
1:2.6 which is comparable to reports from many
countries. A case-control study based on the Oxford
Record Linkage about 70 percent of the children with
anencephaly and 60 percent of the children with
spina bifida were females (32). The sex distribution
in the Thailand 10 years review, however, was equal
among NTD cases with 55 (48%) females, 59 (51%)
males and one (1%) unidentified sex (29).
Although 95% of mothers whose pregnancy outcome
complicated by NTDs had ANC follow-up only 12%
of them were diagnosed before 28 weeks of gestation
and the mean gestational age at the time of diagnosis
was 33.9 week ±5.6 weeks. This clearly shows the
failure of the ANC service in our setup to timely di-
agnose NTDs. Detecting lethal congenital anomalies
early and termination in the first trimester could have
avoided caring anomalous fetus to third trimester of
pregnancy and complications associated with late
termination. This problem would have been reduced
by screening all mothers in the second trimester with
ultrasound and determining MSAFP as demonstrated
in high income countries where the prevalence was
reduced by 56% just by screening and terminating
the affected fetus (13).
Limitations of the study: As this study is retrospec-
tive and the study population not representative of
the general population the study findings may not
reflect the national situation.
Conclusion and recommendations: In conclusion,
the prevalence of neural tube defects in this study is
among the highest globally reported rates the most
prevalent NTD being myelomeningocele. The prac-
tice of periconceptional folic acid supplementation in
our setup is negligible. And although most had ANC
follow-up the vast majority of NTDs were diagnosed
late in the third trimester.
Considering the findings of this study and cost of
treatment of NTDs it is highly recommended to con-
sider implementing national preventive strategy to
reduce the prevalence of NTDs in Ethiopia. And
based on lessons learned from other countries; early
screening and periconceptional folic acid supplemen-
tation are the two effective possible approaches to
bring about the required reduction in NTD preva-
lence in the country.
In addition, further large scale prospective studies are
needed to have reliable estimates on burden of
NTDs, associated factors and cost benefit analysis of
screening and preconception folic acid administration
for Ethiopian set-up.
REFERENCES
1. Cloherty JP, Stark A, Eichenwald E. Manual of neonatal care. Lipincots and Williams, 1998.
2. Botto LD, Moore CA, Khoury MJ, Erickson JD. Neural-tube defects. N Engl J Med 1999; 341:1509.
3. Wald NJ, Cuckle, Brock JH, et al. Maternal Serum-alpha-fetoprotein measurement in antenatal screening for
anecephaly and spinal bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in
relation to neural tube defect. Lancet 1977; 1:1323 4.
4. Godfrey, P., Oakley, Jr. Centers for Disease Control and Prevention, Atlanta, GA, USA Bulletn of the World
Health Organization.1998; 76 (SuppI 2): 116-117.
5. De Benoist, B.Conclusions of a WHO Technical Consultation on folate and vitamin B12 deficiencies. Food
Nutr Bull. 2008; 29(2 Suppl): S238-S44. PMid:18709899
6. Lemire RJ: Neural tube defects. JAMA 1988; 259:558.
7. Tunçbilek E, Boduroglu K, Alikasifoglu M. Neural tube defects in Turkey: prevalence, distribution and risk
factor. Turk J Pediatr. 1999;41:299-305.Medline:10770089].
8. Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, Scott JM. Maternal plasma folate and vitamin B12 are
independent risk factors for neural tube defects. Q J Med. 1993;86:703-8. Medline:8265769
9. Bjorklund NK, Gordan R. A hypothesis linking low folate intake to neural tube defects due to failure of post–
translation methylations of the cytoskeletion. Int J Dev Biol. 2006;50:135-41. Medline:16479482 doi:10.1387/
126
ijdb.052102nb.
10. Milunsky A, Alpert E. (1984). "Results and benefits of a maternal serum alpha-fetoprotein screening pro-
gram". JAMA 252 (11): 1438–42.
11. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin
Study Research Group. Lancet 1991; 338:131.
12. Czeizel AE, Dudás I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin
supplementation. N Engl J Med 1992; 327:1832.
13. Morris JK, Wald NJ. Quantifying the decline in the birth prevalence of neural tube defects in England and
Wales. J Med Screen 1999; 6:182.
14. Centers for Disease Control and Prevention (CDC). Neural tube defect surveillance and folic acid intervention
--Texas-Mexico border, 1993-1998. MMWR Morb Mortal Wkly Rep 2000; 49:1.
15. Murphy M, Whiteman D, Stone D, et al. Dietary folate and the prevalence of neural tube defects in the British
Isles: the past two decades. BJOG 2000; 107:885.
16. Klusmann A, Heinrich B, Stöpler H, et al. A decreasing rate of neural tube defects following the recommenda-
tions for periconceptional folic acid supplementation. Acta Paediatr 2005; 94:1538.
17. Berry RJ, Li Z, Erickson JD, et al. Prevention of neural-tube defects with folic acid in China. China-U.S. Col-
laborative Project for Neural Tube Defect Prevention. N Engl J Med 1999; 341: 1485.
18. Lumley J et al. Periconception supplementation with folate and/or multivitamins to prevent The Cochrane
Library, Issue 4, 2001. Chichester, Johns Wiley and sons , 2001
19. De-Regil LM, Fernández-Gaxiola AC, Dowswell T, Peña-Rosas JP. Effects and safety of periconceptional
folate supplementation for preventing birth defects. Cochrane Database Syst Rev 2010; :CD007950.
20. Ethiop Med J. 2009 Jan;47(1):71-6. Pattern of neural tube defects at Tikur Anbessa Hospital, Addis Ababa,
Ethiopia.
21. Ashwin Viswanathan, MD, Leslie Linehan, RN, Sarah Woodrow, Mersha Abebe, Abat Sahlu, Zenebe Gedlie
Damtie, Tadios Munie, Neurosurgery in Ethiopia: A Review of Current Status, Residency Training and Future
Directions 2008 (Volume 17, Issue 3)
22. United Nations. The Millennium Development Goals Report. 2012. Available at: http://mdgs.un.org/unsd/
mdg/Resources/Static/Products/Progress2012/English2012.pdf#page=28. Accessed 20th April 2013.
23. Christianson A, Howson CP, Modell B. Global Report on Birth Defects: The Hidden Toll of Dying and Dis-
abled children. March of Dimes. 2006. Available at: http://www.marchofdimes.com/mission/globalprograms
birth defects report. html. Accessed 20th April 2013.
24. Edmonds KD, Overton TG. Antenatal Care. In: Dewhurst Text book of Obstetrics and Gynaecology for Post-
graduate. 7th ed. Oxford: Black-Well Science; 2006; 45: 572-5.
25. Wald NJ. Folic Acid, Pernicious Anaemia and prevention of neural tube defects. Lancet 1994; 343: 30-9.
26. Shubha phadke and Meenal Agarwal Neural tube defects: A need for population-based prevention program
indian J Hum Genet. 2012 May-Aug; 18(2): 145–47.
27. Mohammed Adem Mohammed, Abdulhalik workicho Bushra, Hisham S. Aljadhey, Jemal Hussein Ahmed,
Supplement Use Among Pregnant Women in Ethiopia Prevalence and Predictors Department of Public Health
and Clinical Sciences, Faculty of Health Sciences, Jigjiga University, Jigjiga, Ethiopia May 2013, 47 (3)
28. Golalipour, MJ; Mobasheri, E.; Vakili,; & Keshtkar, AA. (2007). Epidemiology of neural tube defects in
Northern Iran, 1998-2003. Eastern Mediterr Health J, Vol.3, pp. 560-66, ISSN 1020-3397
29. Wasant P, Sathienkijkanchai A. J Med Assoc Thai. Neural tube defects at Siriraj Hospital, Bangkok, Thailand
10 years review (1990-1999). 2005 Nov; 88 Suppl 8:S92-9
30. Harris, JA. & James, L. (1997). State-by-state cost of birth defects-1992. Teratology, Vol.56, pp. 11-16, ISSN
0040-3709.
31. Soumaya, SG. et al (2001). Encephalocele:26 retrospective cases at the maternal and neonatal center of La
Rabta, Tunis. Tunis Med, Vol.79, pp. 51-53, ISSN 0041-4131.
32. Whiteman D, Murphy M, Hey K, O. Donnell M, Goldacre M. Reproductive factors, sub fertility and risk of
neural tube defects: a case-control study based on the Oxford Record Linkage Study Register. American Jour-
nal of Epidemiology 2000;152(9): 823-28.
... Despite being a significant cause of perinatal morbidity and mortality, NTDs are preventable. Anencephalic children typically do not survive beyond birth, while those with meningocele and myelomeningocele have higher survival rates due to medical and surgical intervention [2,3]. ...
... NTDs are associated with substantial mortality, morbidity, disability, and psychological and economic costs in which an estimated 13% of neonatal deaths attributed to birth defects in low resource countries [3]. In Ethiopia, the prevalence of NTD reported as 10.9 per 1000 pregnancies in Debere Birhan referral hospital and 4.2/1000 in Addis Ababa [4]. ...
Article
Full-text available
Background Neural tube defects (NTDs) account for the largest proportion of congenital anomalies of the central nervous system and result from failure of the neural tube to close spontaneously between the 3rd and 4th weeks of in utero development. Prognosis and treatment outcome depends on the nature and the pattern of the defect. The nature of treatment outcomes and its pattern associated with grave prognosis is not well known in the study area. Objective The aim of study was to determine the patterns and short term neurosurgical management outcomes of newborns with neural tube defects admitted at Felege Hiwot Specialized Hospital. Methods Institutional based retrospective cross-sectional study among neonates, who were admitted at Felege Hiwot Specialized Hospital with neural tube defects from January 1st to December, 30th, 2018 was conducted. All Charts of Neonates with confirmed diagnosis of neural tube defects were included as part of the study. Trained data collectors (medical interns) supervised by trained supervisors (general practitioners) collected the data using a pretested data extraction format. Data were coded, entered and analyzed using SPSS version 23 software. Frequency and cross tabulations were used to summarize descriptive statistics of data, and tables and graphs were used for data presentation. Result About 109 patients had complete documentation and imaging confirmed neural tube defects. Myelomeningocele was the commonest pattern 70 (64.2%). Thoracolumbar spine was the commonest site of presentation 49(45%). The most common associated impairment was hydrocephalus 37(33.9%). Forty-five (41.1%) had multiple complications. The mortality rate was 7.3%, 44% were discharged with sequalae and 36.7% were discharged without impairment. The significant causes of death were infection 66.7% and Chiari crisis 33.3%. Conclusion Myelomeningocele was the most frequent clinical pattern of neural tube defect and thoracolumbar spine was the commonest site. Isolated neural tube defect was the commonest finding. There were multiple complications after surgery accompanied with meningitis and hydrocephalus. The mortality rate among neonates with neural tube defects was considerably high. The commonest causes of death were infection and Chiari crisis.
Article
Full-text available
Background Neural tube defects are severe congenital malformations secondary to an abnormal closure of the neural tube between third and fourth weeks of gestational ages. Neural tube defects affect birth outcomes worldwide, with an occurrence of 18.6 per 10,000 live births. In addition, neural tube defects are associated with considerable mortality, morbidity, disability, and socio-economical cost. Objective To identify factors associated with neural tube defects among newborns delivered at Debre Berhan Comprehensive Specialized Hospital, 2021. Methods Facility-based case-control study design was conducted among 381 (127 cases and 254 controls) newborns delivered from June 2019 to June 2021 at Debre Berhan Specialized Hospital. Consecutive and systematic random sampling techniques were used to select cases and controls, respectively. Data were collected using semi-structured checklists. Finally, data were entered using Epidata version 4.2.1 and analyzed using SPSS version 25. In the bivariable logistic regression model, factors with a p < 0.20 were entered into multivariable logistic regressions. Statistical significance was declared at a p < 0.05. Result In this study, 381 newborns (127 cases and 254 controls) participated with a response rate of 100%. In the logistic regression model, mothers who took medication during pregnancy [AOR 1.83 (95% CI 1.08–3.08)], mothers who did not take a balanced diet during pregnancy [AOR 13.46 (95% CI 7.83–23.13)], and mothers who did not take folic acid before and during the first trimester of pregnancy [AOR 1.71 (95% CI 1.01–2.94)] were significantly associated with neural tube defect. Conclusion and Recommendation Mothers who took medication during pregnancy, mothers who did not take balanced diets during pregnancy, and mothers who did not take folic acid during pregnancy were the significant factors of neural tube defects. Health care professionals should focus on maternal safe drug prescription, maternal folate intake, and a balanced diet before and during pregnancy.
Article
Background Neural tube defects are one of the most common malformations with a worldwide prevalence of 1-3 per1000 live births. They are the result of failure of the neural tube to close during the 21-28 embryonic days and it had multi-factorial etiology. Objective The aim of this study was to assess the determinants of neural tube defects at Zewditu Memorial hospital in Addis Ababa, Ethiopia. Method A hospital based unmatched case control study was conducted with a ratio of 1:2 cases to control cases and a total of 60 cases and 120 controls were selected. Data was collected using a structured questionnaire. Data analysis was conducted using SPSS version 23 software. Results were summarized using descriptive statistics. Bivariate and multivariate logistic regression analyses were conducted for statistical testing. Statistical association was declared with p-value less than 0.05. Results The results show that oral contraceptive use, young maternal age, parental low educational status, hot tub use, passive smoking, caffeine consumption of ≥3 cup/day, maternal occupation, family history of neural tube defects, maternal fever and being multiparous had an association with neural tube defects. In the multivariate analysis, maternal fever (OR 65.5 CI 4.4 - 957.9), family history of neural tube defects (OR 43.5 CI 1.2-1506.9), coffee consumption (OR 18.5 CI 3.7-91.1), antipyretic use (OR 0.01 CI .00 -.53) and maternal age of <19 (OR 33.3 CI 2.5-448.4) and 25 -29 (OR 9.7 CI 1.3-67.6) had a significant association with neural tube defects. Conclusion This study shows that maternal fever, family history of neural tube defects, coffee consumption, and young maternal age were associated with the increasing the risk of neural tube defect whereas antipyretic drug use had a protective effect.
Article
Introduction Closure of neural tube defects in children is a common neurosurgical procedure in Ethiopia, but we know little about the outcomes. The aim of this study is to study outcomes, and to identify predictors of mortality and morbidity of surgically treated NTDs. Patients Between July 2013 and August 2014, all patients operated for NTDs were prospectively registered in a database and followed for a minimum of 4 years after the initial surgery. Results A total of 88 children primary operated for NTDs closure in the period between July, 2013 to August, 2014 were included in the study. The median age at primary NTD closure was 29 days. The commonest site of defect was lumbar (60.2%) followed by lumbosacral (11.4%). There was no perioperative mortality but 23 (26.1%) of the children developed wound related complications including CSF leak and infection. Preoperative CSF leakage (P=0.013) associated with risk of postoperative complications. We acquired 4-years follow-up data for 61(69%) of the cases. At four years, 25(41%) of these children were dead. Presence of hydrocephalus and reduced motor function were found to be negative predictors for survival. Conclusions Over all, the prognosis was poor. The study provides a basis for identifying patients at risk in order to improve the standard of care.
Article
Full-text available
Background: Congenital anomalies are the fifth leading cause of under-5 mortality globally. The greatest burden is faced by those in low/middle-income countries (LMICs), where over 95% of deaths occur. Many of these deaths may be preventable through antenatal diagnosis and early intervention. This systematic literature review investigates the use of antenatal ultrasound to diagnose congenital anomalies and improve the health outcomes of infants in LMICs. Methods: A systematic literature review was conducted using three search strings: (1) structural congenital anomalies; (2) LMICs; and (3) antenatal diagnosis. The search was conducted on the following databases: Medline, Embase, PubMed and the Cochrane Library. Title, abstract and full-text screening was undertaken in duplicate by two reviewers independently. Consensus among the wider authorship was sought for discrepancies. The primary analysis focused on the availability and effectiveness of antenatal ultrasound for diagnosing structural congenital anomalies. Secondary outcomes included neonatal morbidity and mortality, termination rates, referral rates for further antenatal care and training level of the ultrasonographer. Relevant policy data were sought. Results: The search produced 4062 articles; 97 were included in the review. The median percentage of women receiving an antenatal ultrasound examination was 50.0% in African studies and 90.7% in Asian studies (range 6.8%–98.8%). Median detection rates were: 16.7% Africa, 34.3% South America, 34.7% Asia and 47.3% Europe (range 0%–100%). The training level of the ultrasound provider may affect detection rates. Four articles compared morbidity and mortality outcomes, with inconclusive results. Significant variations in termination rates were found (0%–98.3%). No articles addressed referral rates. Conclusion: Antenatal detection of congenital anomalies remains highly variable across LMICs and is particularly low in sub-Saharan Africa. Further research is required to investigate the role of antenatal diagnosis for improving survival from congenital anomalies in LMICs. PROSPERO registration number CRD42019105620.
Article
Full-text available
Background The epidemiology of neural tube defect (NTD) is face ignorance from the global community. However, the problem is complex and it is a cause for child mortality and morbidity. We provide the latest insights with respect to determinant factors of NTD. Methods Google Scholar and PubMed were systematically searched to identify potential research articles concerning the epidemiology and its determinant factors of NTD. Results The epidemiology of Neural tube defects increased in some countries. The epidemiology and determinant factors were varies across countries,geographical regions and socioeconomic status of the populations. In general, the determinant factors of NTD were summarized as behavioral, nutrition-related, environmental, medical illness, and health service-related factors. Conclusion Birth defect is fatal which affects the new generation; specifically, NTD is the problem of middle - and low-income countries. It is a direct cause for neonatal and perinatal mortality rate globally. Even if little factors identified, yet conducting experimental and clinical trial researches are a better approach to slow down the progress.
Article
Full-text available
Introduction Neural tube defects are the major causes of fetal loss and considerable disabilities in infants. Currently, there is no significant research on the incidence of Neural tube defects in the Tigray region of Ethiopia. Objective To determine the incidence and clinical pattern of the Neural Tube Defects. Methods A hospital-based cross-sectional study was conducted from October 2016 to June 2017. All pregnancy outcomes were examined for any externally visible birth defects and neurological integrity by trained midwives under the supervision of senior obstetrics and gynecology and a neurosurgeon. Data were collected using a survey tool to collect maternal and newborn demographic data and a checklist developed to capture newborns with Neural Tube Defects. Data were analyzed using SPSS version 20. The prevalence of NTDs was calculated per 10,000 births. Result Out of the 14,903 births during the study period, a total of 195 infants were born afflicted with Neural Tube Defects. The burden of infants with anencephaly and spina bifida was 66.4 and 64.4 per 10, 000 births, respectively. The overall incidence rate of NTDs in this study was 131 per 10, 000 births of which 23% were liveborn and 77% were stillborn. The highest burden of Neural Tube Defects was observed in Adigrat Hospital from Eastern Zone of Tigray (174 per 10,000 births) and Lemlem Karl Hospital from Southern Zone of Tigray (304 per 10,000 births) compared to Kahsay Abera Hospital from Western Zone (72.8 per 10,000 births) and Sihul Hospital from North Western Zone of Tigray (69.8 per 10,000 births). Conclusion and recommendation Assuming that the non folic acid preventable rate should be 5 per 10,000 births, our prevalence rate is 131 per 10,000 births, and then we have a rate or an epidemic that is 26 times what it should be. This just emphasizes the urgency to implement effective programs to get all women of reproductive age to have adequate folic acid to prevent all of folic acid-preventable spina bifida and anencephaly, which would prevent 96% (125/130) of spina bifida and anencephaly in the Tigray Provence.
Article
Full-text available
The risk of recurrent neural-tube defects is decreased in women who take folic acid or multivitamins containing such during the periconceptional period. The extent to which folic acid supplementation can reduce the first occurrence of defects is not known. We conducted a randomized, controlled trial of periconceptional multivitamin supplementation to test the efficacy of this treatment in reducing the incidence of a first occurrence of neural-tube defects. Women planning a pregnancy (in most cases their first) were randomly assigned to receive a single tablet of a vitamin supplement (containing 12 vitamins, including 0.8 mg of folic acid; 4 minerals; and 3 trace elements) or a trace-element supplement (containing copper, manganese, zinc, and a very low dose of vitamin C) daily for at least one month before conception and until the date of the second missed menstrual period or later. Pregnancy was confirmed in 4753 women. The outcome of the pregnancy (whether the fetus or infant had a neural-tube defect or congenital malformation) was known in 2104 women who received the vitamin supplement and in 2052 who received the trace-element supplement. Congenital malformations were significantly more prevalent in the group receiving the trace-element supplement than in the vitamin-supplement group (22.9 per 1000 vs. 13.3 per 1000, P = 0.02). There were six cases of neural-tube defects in the group receiving the trace-element supplement, as compared with none in the vitamin-supplement group (P = 0.029). The prevalence of cleft lip with or without cleft palate was not reduced by periconceptional vitamin supplementation. Periconceptional vitamin use decreases the incidence of a first occurrence of neural-tube defects.
Article
Objectives To measure the changes in folate consumption and the prevalence of neural tube defects in the British and Irish populations during the past two decades. Design Ecological study. Main outcome measures Average daily dietary folate consumption for Britain for the period 1980–1996 was estimated from the National Food Survey. Annual neural tube defect prevalences for the same period were obtained from the Oxford Record Linkage Study Neural Tube Defect register, the Glasgow EUROCAT register, and the three Irish EUROCAT registers (Belfast, Dublin and Galway). Results Dietary folate consumption increased on average by 1.6% per annum in Scotland and 1.4% in England during the study period. The annual rate of decline of neural tube defect prevalence averaged 10.4% in the Irish population, 8.2% in Glasgow, and 5.2% in Oxfordshire and West Berkshire. Conclusions The decline in neural tube defect prevalence observed in all British and Irish populations since the early 1970s continued with the introduction of folate fortification of cereals, which produced measurable increases in average daily folate consumption. Further declines in neural tube defect prevalence may be achieved by targeted folate supplementation during the periconceptual period.
Article
It has been reported that neural tube defects can be prevented with periconceptional folic acid supplementation. The effects of different doses, forms and schemes of folate supplementation for the prevention of other birth defects and maternal and infant outcomes are unclear. This review updates and expands a previous Cochrane Review assessing the effects of periconceptional supplementation with folic acid to reduce neural tube defects (NTDs). We examined whether folate supplementation before and during early pregnancy can reduce neural tube and other birth defects (including cleft palate) without causing adverse outcomes for mothers or babies. We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (July 2010). Additionally, we searched the international clinical trials registry platform and contacted relevant organisations to identify ongoing and unpublished studies. We included all randomised or quasi-randomised trials evaluating the effect of periconceptional folate supplementation alone, or in combination with other vitamins and minerals, in women independent of age and parity. We assessed trials for methodological quality using the standard Cochrane criteria. Two authors independently assessed the trials for inclusion, one author extracted data and a second checked for accuracy. Five trials involving 6105 women (1949 with a history of a pregnancy affected by a NTD and 4156 with no history of NTDs) were included. Overall, the results are consistent in showing a protective effect of daily folic acid supplementation (alone or in combination with other vitamins and minerals) in preventing NTDs compared with no interventions/placebo or vitamins and minerals without folic acid (risk ratio (RR) 0.28, 95% confidence interval (CI) 0.15 to 0.52). Only one study assessed the incidence of NTDs and the effect was not statistically significant (RR 0.08, 95% CI 0.00 to 1.33) although no events were found in the group that received folic acid. Folic acid had a significant protective effect for reoccurrence (RR 0.32, 95% CI 0.17 to 0.60). There is no statistically significant evidence of any effects on prevention of cleft palate, cleft lip, congenital cardiovascular defects, miscarriages or any other birth defects. There were no included trials assessing the effects of this intervention on maternal blood folate or anaemia at term.We found no evidence of short-term side effects. Folic acid, alone or in combination with vitamins and minerals, prevents NTDs but does not have a clear effect on other birth defects.
Article
Every year an estimated 8 million children (6 percent of total births worldwide) are born with a serious birth defect of genetic or partially genetic origin. Additionally, hundreds of thousands more are born with serious birth defects of post-conception origin due to maternal exposure to environmental agents. At least 3.3 million children less than 5 years of age die annually because of serious birth defects and the majority of those who survive may be mentally and physically disabled for life. This new report from the March of Dimes is the first to provide a global estimate of serious birth defects of genetic or partly genetic origin. It details the birth prevalence rates and the numbers of affected births in 193 countries. The report recommends steps that can be taken to prevent birth defects and improve the care of those affected in developing countries. Experience from high-income countries shows that overall mortality and disability from birth defects could be reduced by up to 70 percent if the recommendations in this report are broadly implemented.
Article
Folate and vitamin B12 deficiencies occur primarily as a result of insufficient dietary intake or, especially in the case of vitamin B12 deficiency in the elderly, poor absorption. Folate is present in high concentrations in legumes, leafy green vegetables, and some fruits, so lower intakes can be expected where the staple diet consists of unfortified wheat, maize, or rice, and when the intake of legumes and folate-rich vegetables and fruits is low. This situation can occur in both wealthy and poorer countries. Animal-source foods are the only natural source of vitamin B12, so deficiency is prevalent when intake of these foods is low due to their high cost, lack of availability, or cultural or religious beliefs. Deficiency is certainly more prevalent in strict vegetarians, but lacto-ovo vegetarians are also at higher risk for inadequate intakes. If the mother is folate-depleted during lactation, breastmilk concentrations of the vitamin are maintained while the mother becomes more depleted. In contrast, vitamin B12 concentrations in breastmilk can be markedly lower in vitamin B12-depleted women. The impact of gene polymorphisms on folate and vitamin B12 status and requirements in a population will vary depending on the underlying prevalence in that population. Although not well understood, gene polymorphisms almost certainly affect the risk of adverse pregnancy outcomes. Folic acid and vitamin B12 in synthetic form are absorbed at about twice the efficiency as the food forms, especially in lower doses.
Article
Nineteen centres collaborated in a study to determine the efficiency of maternal serum-alpha-fetoprotein (A.F.P.) measurement as a method of screening for neural-tube defects (N.T.D.S.) between 10 and 24 weeks of pregnancy. Data were collected on 18 684 singleton pregnancies and 163 twin pregnancies without fetal N.T.D.s, and on 301 singleton pregnancies with fetal N.T.D.s (146 with anencephaly, 142 with spina bifida, and 13 with encephalocele). The best time for detecting open spina bifida by measuring maternal serum-A.F.P. is at 16-18 weeks of pregnancy. In clinical practice, serum-A.F.P. cut-off levels expressed as multiples of the normal median may be more convenient to use than percentiles because they are easier to derive and more stable. Also, the proportion of affected pregnancies with serum-A.F.P. levels exceeding a given multiple of the median is unlikely to vary significantly from centre to centre or over time. In contrast, the proportion of unaffected pregnancies with A.F.P. levels exceeding a given multiple of the normal median will vary depending on the precision with which serum-A.F.P. and gestation are measured. At 16-18 weeks of pregnancy 88% of cases of anencephaly, 79% of cases of open spina bifida, and 3% of unaffected singleton pregnancies had A.F.P. levels equal to or greater than 2-5 times the median for unaffected singleton pregnancies. At this gestation age the numbers of unaffected pregnancies with A.F.P. levels above 2-5 times the normal median can be reduced by about a third if women with borderline A.F.P. levels are retested, although this would not greatly change the detection-rate of affected pregnancies. In the United Kingdom as a whole, women with serum-A.F.P. levels above 2-5 times the normal median at 16-18 weeks of gestation will have an approximately 1-in-20 chance of having a fetus with open spina bifida; the risk of having any N.T.D. will be approximately 1 in 10. The results of this study indicate that screening pregnant women by measuring the concentration of A.F.P. in their serum is an effective method of selecting women for ultrasonography and amniocentesis so that N.T.D.s can be diagnosed in utero.
Article
Neural tube defects (NTDs) are a group of malformations of the brain and spinal cord that originate at various times during gestation. The most common NTDs are anencephaly and meningomyelocele, which arise during the process of neurulation, a well-defined period between the 17th and 30th day after ovulation. These NTDs are clinically apparent by being open, ie, leaving nervous tissue exposed, in contrast to postneurulation NTDs that are skin covered. The incidence of NTDs is declining in several areas of the world, including the United States. While the reasons for this are unclear, there seems to be some effect from prenatal diagnosis, genetic counseling, and possibly nutritional supplementation.
Article
Maternal serum α-fetoprotein (MSAFP) screening was offered in a private suburban practice to 21,000 nondiabetic and 442 diabetic women with apparently normal pregnancies. Using 2.5 or greater multiples of the median as the normal upper limit, 249 (1.2%) had a raised MSAFP level. There were 25 neural tube defects (NTDs) (1.2/1,000 births); 18 were detected by screening and two by ultrasound scanning. Three had closed spina bifida lesions. Two had anencephaly with normal MSAFP levels, but were studied at more than 24 weeks' gestation. An additional 13 with raised MSAFP levels had other congenital defects. One in 400 women screened had a recommended amniocentesis; 26.4% of them had a fetus with an NTD or major malformation. Our detection efficiency before 24 weeks' gestation for anencephaly was 85.7% (12/14), 62.5% (5/8) for open and closed spina bifida, and 1/1 for encephalocele. A raised MSAFP level occurred in ten (2.3%) of the 442 diabetic women, four (0.9%) of whom had a fetus with an open NTS. A screening program should be established only where there is linked excellent interdisciplinary support among obstetrician, laboratory, clinical geneticist, ultrasonographer, and an identified program coordinator. (JAMA 1984;252:1438-1442)